Variant report
Variant | esv18077 |
---|---|
Chromosome Location | chr2:34921795-34924020 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs150982007 | chr2:34921797-34921798 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs189328573 | chr2:34921799-34921800 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs527988087 | chr2:34921800-34921801 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs555667325 | chr2:34921807-34921808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs13004134 | chr2:34921812-34921813 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs537801045 | chr2:34921813-34921814 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs555496516 | chr2:34921818-34921819 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs117010435 | chr2:34921838-34921839 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs373769807 | chr2:34921850-34921851 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs150003131 | chr2:34921853-34921854 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs146587034 | chr2:34921864-34921865 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs573233162 | chr2:34921874-34921875 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs542131018 | chr2:34921879-34921880 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs562375112 | chr2:34921890-34921891 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs4670395 | chr2:34921899-34921900 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs145008282 | chr2:34921914-34921915 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs564472047 | chr2:34921928-34921929 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs191832240 | chr2:34921934-34921935 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs372795317 | chr2:34921941-34921942 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs138990117 | chr2:34921978-34921979 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs546852123 | chr2:34922013-34922014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs566688974 | chr2:34922029-34922030 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs538270706 | chr2:34922041-34922042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs115363077 | chr2:34922066-34922067 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs376758391 | chr2:34922070-34922071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs549010478 | chr2:34922079-34922080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs112012521 | chr2:34922080-34922081 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs533434172 | chr2:34922099-34922100 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs551352312 | chr2:34922108-34922109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs148134505 | chr2:34922133-34922134 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs539087253 | chr2:34922141-34922142 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs553415262 | chr2:34922155-34922156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs183909560 | chr2:34922161-34922162 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs189129488 | chr2:34922166-34922167 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs141965075 | chr2:34922167-34922168 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs181569430 | chr2:34922178-34922179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs372552231 | chr2:34922181-34922182 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs573112208 | chr2:34922192-34922193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs186768870 | chr2:34922203-34922204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs150105565 | chr2:34922211-34922212 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs62163864 | chr2:34922224-34922225 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs190466942 | chr2:34922232-34922233 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs138747049 | chr2:34922390-34922391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs562685203 | chr2:34922395-34922396 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs182240691 | chr2:34922409-34922410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs551122519 | chr2:34922476-34922477 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs570924837 | chr2:34922498-34922499 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs533514470 | chr2:34922499-34922500 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs186085996 | chr2:34922514-34922515 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs567016115 | chr2:34922521-34922522 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17393978 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 19521722 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21364760 | CNVD |
Wilms tumour | 21544195 | CNVD |
Non-small cell lung cancer | 18927303 | CNVD |
Hereditary gingival fibromatosis | 19633868 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Neurocytoma | 17123091 | CNVD |
Autism | 22495309 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:34919600-34926000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |